Download PDF
Laryngorhinootologie 2020; 99(06): 370-373
DOI: 10.1055/a-1168-0855
Leitlinien und Empfehlungen

Short Communication: COVID-19-Pandemie und HNO

H.-J. Welkoborsky
1   Klinik für HNO-Heilkunde, Kopf-Halschirurgie, Klinikum Nordstadt, Hannover
,
A. Dietz
2   Univ. HNO-Klinik, Leipzig
,
T. Deitmer
3   Deutsche Gesellschaft für HNO-Heilkunde, Kopf- und Halschirurgie
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Vorbemerkungen

Nach seinem erstmaligem Auftreten Ende 2019 in der chinesischen Stadt Wuhan hat sich das neuartige Coronavirus-19 relativ schnell weltweit verbreitet. Es ist derzeit in nahezu allen Ländern mit regional sehr unterschiedlicher Inzidenz nachgewiesen. Mit dem neuartigen Coronavirus-19-Infizierte können an der durch das Virus verursachten COVID-19 (Syn. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)) erkranken. Nach Auskunft des Robert-Koch-Institutes (RKI) sind am 29.04.2020 weltweit über 3 Mio. Infektionen mit dem Virus nachgewiesen, 216 700 Infizierte sind im Verlaufe der Infektion verstorben, wobei anhand der Daten nicht zu differenzieren ist, ob die COVID-19-Infektion in jedem Fall die unmittelbare Todesursache darstellte, oder die Patienten zwar als Virusträger, aber aus anderer Ursache verstorben sind. Für Deutschland werden am 28.04.2020 157 641 Infizierte angegeben, was einer Inzidenz von 190/100 000 Einwohner entspricht. 6115 Patienten sind im Verlauf der Infektion verstorben, 112 000 Patienten gelten als genesen, so dass sich eine Anzahl an aktiv Infizierten von derzeit etwa 40 000 ergibt, was einer Inzidenz von aktiv Infizierten von ca. 50/100 000 entspricht [1]. Allerdings wird immer wieder auf eine mutmaßlich hohe Dunkelziffer hingewiesen, auch vor dem Hintergrund, dass viele COVID-19-Infizierte klinisch asymptomatisch, aber Virusüberträger sein können [2] [3]. Dies gilt in besonderem Maße auch für Kinder, die nicht oder nur sehr selten symptomatisch erkranken [4] [5].



Publication History

Article published online:
08 May 2020

© Georg Thieme Verlag KG
Stuttgart · New York

 

  • Literatur

  • 1 Robert-Koch-Institut. COVID-19 Fallzahlen in Deutschland und weltweit. www.rki.de , Aufruf am 29.04.2020, 10.15 Uhr
    PubMed
  • 2 Balakrishnan K, Schechtman S, Hogikyan ND. et al. COVID-19 Pandemic: What Every Otolaryngologist-Head and Neck Surgeon Needs to Know for Safe Airway Management. Otolaryngol Head Neck Surg 2020;
    CrossrefPubMedSearch in Google Scholar
  • 3 Cheng X, Liu J, Li N. et al. Otolaryngology Providers Must Be Alert for Patients with Mild and Asymptomatic COVID-19. Otolaryngol Head Neck Surg 2020;
    CrossrefPubMedSearch in Google Scholar
  • 4 Matava CT, Kovatsis PG, Summers JL. et al. PeDI-Collaborative: Pediatric Airway Management in COVID-19 patients – Consensus Guidelines from the Society for Pediatric Anesthesia’s Pediatric Difficult Intubation Collaborative and the Canadian Pediatric Anesthesia Society. Anesth Analg 2020;
    CrossrefPubMedSearch in Google Scholar
  • 5 Parikh SR, Bly RA, Bonilla-Velez J. et al. Sie: Pediatric Otolaryngology Divisional and Institutional Preparatory Response at Seattle Children’s Hospital after COVID-19 Regional Exposure. Otolaryngol Head Neck Surg 2020;
    CrossrefPubMedSearch in Google Scholar
  • 6 Torretta S, Gaini LM, Pignataro L. Why Italian ENT physicians should be aware of SARS-CoV-2. Acta Otorhinolaryngol Ital 2020;
    CrossrefPubMedSearch in Google Scholar
  • 7 Aghagoli G, Gallo Marin B, Soliman LB. et al. Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review. J Card Surg 2020;
    CrossrefPubMedSearch in Google Scholar
  • 8 Saibene AM, Allevi F, Biglioli F. et al. Role and Management of a Head and Neck Department during the COVID-19 Outbreak in Lombardy. Otolaryngol Head Neck Surg 2020;
    CrossrefPubMedSearch in Google Scholar
  • 9 Costanzo M, De Giglio MAR, Roviello GN. SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the Treatment of the New Coronavirus. Curr Med Chem 2020;
    CrossrefPubMedSearch in Google Scholar
  • 10 Zou L, Ruan F, Huang M. et al. SARS-CoV-2 Viral load in upper respiratory specimens of infected patients. N Engl J Med 2020;
    CrossrefPubMedSearch in Google Scholar
  • 11 Lu D, Wang H, Yu R. et al. Integrated infection control strategy to. Minimize nosocomial infection of corona virus disease 2019 among ENT healthcare workers. J Hosp Infect 2020;
    CrossrefPubMedSearch in Google Scholar
  • 12 Wang D, Hu B, Hu C. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus infected pneumonia in Wuhan, China. JAMA – J Am Med Assoc 2020; 323: 1061-1069
    PubMedSearch in Google Scholar
  • 13 Adams JG, Walls RM. Supporting the Health Care Workforce During the COVID-19 Global Epidemic. JAMA 2020; 323 (15) 1439-1440 . doi:10.1001/jama.2020.3972
    CrossrefPubMedSearch in Google Scholar
  • 14 Krajewska J, Krajewski W, Zub K. et al. COVID-19 in otolaryngologist practice: a review of current knowledge. Eur Arch Otorhinolaryngol 2020;
    CrossrefPubMedSearch in Google Scholar
  • 15 Lovato A, de Filippis C, Marioni G. Upper airway symptoms in coronavirus disease 2019 (COVID-19). Am J Otolaryngol 2020;
    CrossrefPubMedSearch in Google Scholar
  • 16 Asadi-Pooya AA, Simani L. Central nervous system manifestations of COVID-19: A systematic review. J Neurol Sci 2020; 413: 116832 . doi:10.1016/j.jns.2020.116832
    CrossrefPubMedSearch in Google Scholar
  • 17 Siordia Jr JA. Epidemiology and clinical features of COVID-19: A review of current literature. J Clin Virol 2020; 127: 104357 . doi: 10.1016/j.jcv.2020.104357
    CrossrefPubMedSearch in Google Scholar
  • 18 Xiang F, Wang X, He X. et al. Antibody Detection and Dynamic Characteristics in Patients with COVID-19. Clin Infect Dis 2020;
    CrossrefPubMedSearch in Google Scholar
  • 19 Sriwijitalai W, Wiwanitkit V. Hearing loss and COVID-19: A Note. Am J Otolaryngol 2020;
    CrossrefPubMedSearch in Google Scholar
  • 20 Trecca EMC, Gelardi M, Cassano M. COVID-19 and hearing difficulties. Am J Otolaryngol
    PubMed
  • 21 Mustafa MWM. Audiological profile of asymptomatic COVID-19 PCR positive cases. Am J Otolaryngol 2020;
    CrossrefPubMedSearch in Google Scholar
  • 22 Vukkadala N, Qian ZJ, Holsinger FC. et al. COVID-19 and the otolaryngologist – preliminary evidence-based review. Laryngoscope 2020;
    CrossrefPubMedSearch in Google Scholar
  • 23 Centers for Disease Control and Prevention (CDC). Interim infection prevention and control recommendations for patients with confirmed coronavirus disease 2019 (COVID-19) or persons under investigation for COVID-19 in healthcare settings. https://www.cdc.gov/coronavirus/2019-ncov/infection-control/control-recommendations.html
    PubMed
  • 24 Richardson S, Hirsch JS, Narasimhan M. et al Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA, J Americ Med Assoc Published online April 22, 2020
    PubMed
  • 25 Chow EJ, Schwartz NG, Tobolowsky FA. et al Symptom screening at illness onset of health care personel with SARS-CoV-2 Infection in Kong County, Washington. JAMA Americ Med Ass, Apr. 17, 2020, publiziert online: https://jamanetwork.com
    PubMed
  • 26 Givi B, Schiff BA, Chinn SB. et al. Safety Recommendations for Evaluation and Surgery of the Head and Neck During the COVID-19 Pandemic. JAMA Otolaryngol Head Neck Surg 2020;
    CrossrefPubMedSearch in Google Scholar
  • 27 Patel ZM, Fernandez-Miranda J, Hwang PH. et al. Letter: Precautions for Endoscopic Transnasal Skull Base Surgery During the COVID-19 Pandemic. Neurosurgery 2020;
    CrossrefPubMedSearch in Google Scholar
  • 28 Workman AD, Welling DB, Carter BS. et al. Endonasal instrumentation and aerosolization risk in the era of COVID-19: simulation, literature review, and proposed mitigation strategies. Int Forum Allergy Rhinol 2020;
    CrossrefPubMedSearch in Google Scholar
  • 29 American College of Surgeons (ACS). Local Resumption of Elective Surgery Guidance. Publ. Online (abgerufen 22.04.2020): www.FACS.org
    PubMed
  • 30 Dexter F, Parra MC, Brown JR. et al. Perioperative COVID-19 Defense: An Evidence-Based Approach for Optimization of Infection Control and Operating Room Management. Anesth Analg 2020;
    CrossrefPubMedSearch in Google Scholar